Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Pevonedistat in Combination With Carboplatin and Paclitaxel in Advanced Intrahepatic Cholangiocarcinoma

NCT04175912 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04175912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04175912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Pevonedistat in Combination With Carboplatin and Paclitaxel in Advanced Intrahepatic Cholangiocarcinoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 16, 2020
Completion date
September 3, 2027
Enrollment
40 (actual)
Sites
419

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cholangiocarcinoma, metastatic hepatocellular carcinoma, stage iii hepatocellular carcinoma ajcc v8, stage iii intrahepatic cholangiocarcinoma ajcc v8, stage iiia hepatocellular carcinoma ajcc v8, stage iiia intrahepatic cholangiocarcinoma ajcc v8, stage iiib hepatocellular carcinoma ajcc v8, stage iiib intrahepatic cholangiocarcinoma ajcc v8, stage iv hepatocellular carcinoma ajcc v8, stage iv intrahepatic cholangiocarcinoma ajcc v8, stage iva hepatocellular carcinoma ajcc v8, stage ivb hepatocellular carcinoma ajcc v8, unresectable cholangiocarcinoma, unresectable hepatocellular carcinoma, unresectable intrahepatic cholangiocarcinoma